| Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha-and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated … D Maurer, S Fiebiger, C Ebner, B Reininger, GF Fischer, S Wichlas, ... Journal of immunology (Baltimore, Md.: 1950) 157 (2), 607-616, 1996 | 351 | 1996 |
| Survival, maturation, and function of CD11c− and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines N Kohrgruber, N Halanek, M Gröger, D Winter, K Rappersberger, ... The Journal of Immunology 163 (6), 3250-3259, 1999 | 300 | 1999 |
| EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris–Part 1: treatment and monitoring recommendations A Nast, C Smith, PI Spuls, G Avila Valle, Z Bata‐Csörgö, H Boonen, ... Journal of the European Academy of Dermatology and Venereology 34 (11), 2461 …, 2020 | 258* | 2020 |
| A TNF-α promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis T Höhler, A Kruger, PM Schneider, RE Schopf, J Knop, C Rittner, ... Journal of Investigative Dermatology 109 (4), 562-565, 1997 | 255 | 1997 |
| Genomewide scan in German families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13 YA Lee, F Rüschendorf, C Windemuth, M Schmitt-Egenolf, A Stadelmann, ... The American Journal of Human Genetics 67 (4), 1020-1024, 2000 | 199 | 2000 |
| Severity of psoriasis differs between men and women: a study of the clinical outcome measure psoriasis area and severity index (PASI) in 5438 Swedish register patients D Hägg, A Sundström, M Eriksson, M Schmitt-Egenolf American journal of clinical dermatology 18, 583-590, 2017 | 175 | 2017 |
| Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1* 0701-DQA1* 0201-DQB1* 0303: a … M Schmitt-Egenolf, TH Eiermann, WH Boehncke, M Ständer, W Sterry Journal of investigative dermatology 106 (4), 711-714, 1996 | 159 | 1996 |
| The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men D Hägg, M Eriksson, A Sundström, M Schmitt-Egenolf PloS one 8 (5), e63619, 2013 | 140 | 2013 |
| Periodontal Ehlers-Danlos syndrome is caused by mutations in C1R and C1S, which encode subcomponents C1r and C1s of complement I Kapferer-Seebacher, M Pepin, R Werner, TJ Aitman, A Nordgren, ... The American Journal of Human Genetics 99 (5), 1005-1014, 2016 | 121 | 2016 |
| Peripheral blood dendritic cells express FceRI as a complex composed of FceRIa-and FceRIg-chains and can use this receptor for IgE-mediated allergen presentation D Maurer, E Fiebiger, C Ebner, B Reininger, GF Fischer, S Wichlas, ... Journal of Immunology 157 (2), 607-616, 1996 | 109 | 1996 |
| Oligonucleotide Typing Reveals Association of Type I Psoriasis with the HLA-DRB1* 0701/2,-DQA* 0201,-DQB1* 0303 Extended Haplotype M Schmitt-Egenolf, WH Boehncke, M Ständer, TH Eiermann, W Sterry Journal of investigative dermatology 100 (6), 749-752, 1993 | 106 | 1993 |
| Association between interleukin‐1 receptor antagonist (IL‐1ra) gene polymorphism and early and late‐onset psoriasis JK Tarlow, MJ Cork, FE Clay, M Schmitt‐Egenolf, AM Crane, C Stierle, ... British Journal of Dermatology 136 (1), 147-148, 1997 | 104 | 1997 |
| Analysis of three outcome measures in moderate to severe psoriasis: a registry‐based study of 2450 patients JM Norlin, K Steen Carlsson, U Persson, M Schmitt‐Egenolf British Journal of Dermatology 166 (4), 797-802, 2012 | 84 | 2012 |
| Psoriasis therapy in real life: the need for registries M Schmitt-Egenolf Dermatology 213 (4), 327-330, 2006 | 63 | 2006 |
| Anti‐TNF treatment during pregnancy and birth outcomes: a population‐based study from Denmark, Finland, and Sweden G Bröms, H Kieler, A Ekbom, M Gissler, K Hellgren, ... Pharmacoepidemiology and Drug Safety 29 (3), 316-327, 2020 | 60 | 2020 |
| Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI) D Hägg, A Sundström, M Eriksson, M Schmitt‐Egenolf Journal of the European Academy of Dermatology and Venereology 29 (3), 452-456, 2015 | 58 | 2015 |
| PsoReg–The Swedish Registry for Systemic Psoriasis TreatmentThe Registry’s Design and Objectives M Schmitt-Egenolf Dermatology 214 (2), 112-117, 2007 | 58 | 2007 |
| Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals. WP Maksymowych, A Wessler, M Schmitt-Egenolf, M Suarez-Almazor, ... The Journal of Rheumatology 21 (4), 665-669, 1994 | 58 | 1994 |
| EDAR mutation in autosomal dominant hypohidrotic ectodermal dysplasia in two Swedish families LK Lind, C Stecksén-Blicks, K Lejon, M Schmitt-Egenolf BMC medical genetics 7, 1-8, 2006 | 52 | 2006 |
| Switch to biological agent in psoriasis significantly improved clinical and patient-reported outcomes in real-world practice JM Norlin, K Steen Carlsson, U Persson, M Schmitt-Egenolf Dermatology 225 (4), 326-332, 2013 | 50 | 2013 |
David HäggVerified email at ki.se
